Clopidogrel

Clopidogrel - most related articles:

- Benefits of anti clotting medications reduced by heartburn drugs - 5.1
- Proton pump inhibitors increase heart attacks in patients on clopidogrel - 4.9
- Prasugrel cuts risk of stent-related clots - 4.4
- Gene variant linked to effectiveness of plavix - 4.1
- Champion clinical trial program of cangrelor discontinued - 3.7
- Evidence based treatments decrease risk of death among heart attack patients - 2.2
- 4 drugs accounted for two thirds of emergency hospitalizations in US - 2.1
- Aspirin resistance increases heart attack, stroke risk - 2.1

Clopidogrel articles

Gene variant linked to effectiveness of plavix
Patients with a certain genetic variation and who received the antiplatelet drug clopidogrel -- Plavix -- had a decreased platelet response to treatment, revealed by researchers.

Benefits of anti clotting medications reduced by heartburn drugs
The anti-clotting action of the medication clopidogrel (Plavix) can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for heart attack, stroke and other serious cardiovascular illnesses, according to a new study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 32nd Annual Scientific Sessions.

Proton pump inhibitors increase heart attacks in patients on clopidogrel
Patients taking the common cardiac drug clopidogrel following a heart attack are at a significantly higher risk of a recurrence if they are also taking widely used acid-lowering medications called proton pump inhibitors.

Prasugrel cuts risk of stent-related clots
The investigational antiplatelet drug prasugrel plus aspirin produced a marked and highly statistically significant reduction in the risk of coronary stent thrombosis (ST) - a major concern for physicians and patients with potentially fatal consequences - in patients who received a stent as compared to standard therapy with clopidogrel (Plavix) plus aspirin, according to a stent analysis from the head-to-head TRITON-TIMI 38 trial.

4 Clopidogrel articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
9.25